The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The Pfizer and Moderna options deliver genetic instructions for the ... Each year, the three manufacturers update their vaccine recipes to better match the latest COVID-19 variants that are ...

Sales of RSV vaccines marketed by Moderna’s rivals, Pfizer PFE and GSK plc GSK, also declined in the first quarter. While sales of Pfizer’s RSV vaccine Abrysvo fell 9% year over year to $131 ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

Moderna's Alexion partnership was terminated in 2017 after failure to find a safe but effective ... enjoyed by other innovative vaccines (GSK's Shingrix, Pfizer's Prevnar) launched in recent ...